MetaVia Inc. business relationships
Companies named in MetaVia Inc.’s 10-K filed 2026-03-26, and public companies whose annual reports name MetaVia Inc.. Each link shows the sentence it came from. Scores are Engagemii’s AI visibility scores.
- AEO visibility
- 4.6 / 10
- AI naming
- 8 / 100 Top 4% in its category
- Agent readiness
- 0 / 100
- AI adoption
- 0 / 100
Layers: PeptidesGLP-1 & obesity
Named in MetaVia Inc.’s annual report 2
“Under the terms of the amended and restated license agreement with Pfizer, Pfizer may currently terminate the license at any time.” SEC filing
“| | ● | | February 2026: Announced positive AI-modeling results from the ongoing collaboration with Syntekabio, Inc., an AI-driven drug discovery company, leveraging their proprietary DeepMatcher® platform.” SEC filing
Links are read automatically from SEC annual reports (10-K, 20-F, 40-F). In a hand check of random links, about 8 in 10 were real business relationships, so every link carries its source sentence.